The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial

References

Page 1

	Year	Citations
Global Prevalence of Diabetes Sarah H. Wild, Gojka Roglić, Anders Green, Diabetes Care	2004	15.2K
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, New England Journal of Medicine	2008	7.6K
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections Hilary King, Ronald E. Aubert, William H. Herman Diabetes Care	1998	6.3K
Consort 2010 statement: extension to cluster randomised trials Marion Campbell, Gilda Piaggio, Diana R Elbourne, BMJ Amyloid AggregationNeurochemical BiomarkersPacked AmyloidSynaptic SignalingConsort 2010	2012	3.4K
Improving Primary Care for Patients With Chronic Illness Thomas Bodenheimer JAMA	2002	2.9K
CONSORT statement: extension to cluster randomised trials Marion Campbell, Diana R Elbourne, Douglas G. Altman BMJ	2004	2.5K
Improving the reporting of pragmatic trials: an extension of the CONSORT statement Merrick Zwarenstein, Shaun Treweek, Joel Gagnier, BMJ	2008	1.7K
Assessing the impact of complications on the costs of Type II diabetes Rhys Williams, L. Van Gaal, Carlo Lucioni Diabetologia Type Ii DiabetesDiabetes ManagementHealth PolicyHealth EconomicsGlobal Health	2002	354
Randomised controlled trial of structured personal care of type 2 diabetes mellitus Niels de Fine Olivarius, Henning Beck‐Nielsen, Anne Helms Andreasen, BMJ	2001	292
Evidence for the effect of disease management: is $1 billion a year a good investment? Soeren Mattke, Michael Seid, Sai Ma PubMed	2007	216

Page 1